CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

SUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate…

SUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate Capsules

Read the official FDA notice

Published
23 Jul 2025
Units affected
5,448 bottles
Agency
FDA
Country
United States

The hazard

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88

Brand / company
SUN PHARMACEUTICAL INDUSTRIES INC
Codes / lots
Lot # AD42648, Exp 02/28/2026
Distribution
Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 23 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.